| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 7.35B | — |
| Operating expense | — | — |
| Net income | 2.06B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NATCOPHARM.NS returned +0.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -2.0% |
| 1 year | +0.5% |
| 5 years | -3.1% |
| 10 years | +39.5% |
| All-time high | ₹1,537.55 (Aug 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in NATCOPHARM.NS would be worth today ›Yes. NATCO Pharma Limited paid 3 dividends over the past 12 months. The most recent was ₹1.50 per share on Aug 20, 2026. The dividend yield is 0.74%.
NATCO Pharma Limited is part of the Healthcare sector.
NATCO Pharma Limited has a market cap of 158.34B INR, based on the latest quote.
NATCO Pharma Limited is scheduled to report earnings on Nov 12, 2026.
